 | • レポートコード：QFJ1-4364 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、95ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査レポートでは、炎症性腸疾患治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（潰瘍性大腸炎、クローン病、その他）、用途別市場規模（病院、医学研究機構、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・炎症性腸疾患治療の市場動向 ・企業の競争状況、市場シェア ・炎症性腸疾患治療の種類別市場規模と予測2016-2027（潰瘍性大腸炎、クローン病、その他） ・炎症性腸疾患治療の用途別市場規模と予測2016-2027（病院、医学研究機構、その他） ・炎症性腸疾患治療の北米市場規模2016-2027（アメリカ、カナダ） ・炎症性腸疾患治療の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・炎症性腸疾患治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・炎症性腸疾患治療の中南米市場規模2016-2027（メキシコ、ブラジル） ・炎症性腸疾患治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Johnson & Johnson、AbbVie、Takeda Pharmaceutical Company、Abbott、Celgene Corporation、Innovate Biopharma、Cosmo Pharmaceuticals、Gilead Sciences、Pfizer） ・結論 |
Inflammatory bowel disease (IBD) is a chronic inflammatory bowel disease of unknown etiology, mainly including ulcerative colitis (UC) and crohn’s disease (CD).The etiology may include environmental, infectious, immune and genetic factors.Because the etiology of inflammatory bowel disease is not clear, clinical symptoms are not specific, easy to be confused with other diseases, so the diagnosis is more difficult.Once misdiagnosis is caused by mistreatment, the result is mild but not cured, serious is life-threatening.The diagnosis of inflammatory bowel disease mainly includes the collection of clinical history, colonoscopy, imaging and mucosal histology.
Market Analysis and Insights: Global Inflammatory Bowel Disease Therapy Market
The global Inflammatory Bowel Disease Therapy market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Inflammatory Bowel Disease Therapy market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Inflammatory Bowel Disease Therapy market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Inflammatory Bowel Disease Therapy market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Inflammatory Bowel Disease Therapy market.
Global Inflammatory Bowel Disease Therapy Scope and Market Size
Inflammatory Bowel Disease Therapy market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Inflammatory Bowel Disease Therapy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Ulcerative Colitis
Crohns Disease
Others
Segment by Application
Hospital
Medical Research Organization
Other
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Johnson & Johnson
AbbVie
Takeda Pharmaceutical Company
Abbott
Celgene Corporation
Innovate Biopharma
Cosmo Pharmaceuticals
Gilead Sciences
Pfizer
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Inflammatory Bowel Disease Therapy Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Ulcerative Colitis
1.2.3 Crohns Disease
1.2.4 Others
1.3 Market by Application
1.3.1 Global Inflammatory Bowel Disease Therapy Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Medical Research Organization
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Inflammatory Bowel Disease Therapy Market Perspective (2016-2027)
2.2 Inflammatory Bowel Disease Therapy Growth Trends by Regions
2.2.1 Inflammatory Bowel Disease Therapy Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Inflammatory Bowel Disease Therapy Historic Market Share by Regions (2016-2021)
2.2.3 Inflammatory Bowel Disease Therapy Forecasted Market Size by Regions (2022-2027)
2.3 Inflammatory Bowel Disease Therapy Industry Dynamic
2.3.1 Inflammatory Bowel Disease Therapy Market Trends
2.3.2 Inflammatory Bowel Disease Therapy Market Drivers
2.3.3 Inflammatory Bowel Disease Therapy Market Challenges
2.3.4 Inflammatory Bowel Disease Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Inflammatory Bowel Disease Therapy Players by Revenue
3.1.1 Global Top Inflammatory Bowel Disease Therapy Players by Revenue (2016-2021)
3.1.2 Global Inflammatory Bowel Disease Therapy Revenue Market Share by Players (2016-2021)
3.2 Global Inflammatory Bowel Disease Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Inflammatory Bowel Disease Therapy Revenue
3.4 Global Inflammatory Bowel Disease Therapy Market Concentration Ratio
3.4.1 Global Inflammatory Bowel Disease Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Inflammatory Bowel Disease Therapy Revenue in 2020
3.5 Inflammatory Bowel Disease Therapy Key Players Head office and Area Served
3.6 Key Players Inflammatory Bowel Disease Therapy Product Solution and Service
3.7 Date of Enter into Inflammatory Bowel Disease Therapy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Inflammatory Bowel Disease Therapy Breakdown Data by Type
4.1 Global Inflammatory Bowel Disease Therapy Historic Market Size by Type (2016-2021)
4.2 Global Inflammatory Bowel Disease Therapy Forecasted Market Size by Type (2022-2027)
5 Inflammatory Bowel Disease Therapy Breakdown Data by Application
5.1 Global Inflammatory Bowel Disease Therapy Historic Market Size by Application (2016-2021)
5.2 Global Inflammatory Bowel Disease Therapy Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Inflammatory Bowel Disease Therapy Market Size (2016-2027)
6.2 North America Inflammatory Bowel Disease Therapy Market Size by Type
6.2.1 North America Inflammatory Bowel Disease Therapy Market Size by Type (2016-2021)
6.2.2 North America Inflammatory Bowel Disease Therapy Market Size by Type (2022-2027)
6.2.3 North America Inflammatory Bowel Disease Therapy Market Size by Type (2016-2027)
6.3 North America Inflammatory Bowel Disease Therapy Market Size by Application
6.3.1 North America Inflammatory Bowel Disease Therapy Market Size by Application (2016-2021)
6.3.2 North America Inflammatory Bowel Disease Therapy Market Size by Application (2022-2027)
6.3.3 North America Inflammatory Bowel Disease Therapy Market Size by Application (2016-2027)
6.4 North America Inflammatory Bowel Disease Therapy Market Size by Country
6.4.1 North America Inflammatory Bowel Disease Therapy Market Size by Country (2016-2021)
6.4.2 North America Inflammatory Bowel Disease Therapy Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Inflammatory Bowel Disease Therapy Market Size (2016-2027)
7.2 Europe Inflammatory Bowel Disease Therapy Market Size by Type
7.2.1 Europe Inflammatory Bowel Disease Therapy Market Size by Type (2016-2021)
7.2.2 Europe Inflammatory Bowel Disease Therapy Market Size by Type (2022-2027)
7.2.3 Europe Inflammatory Bowel Disease Therapy Market Size by Type (2016-2027)
7.3 Europe Inflammatory Bowel Disease Therapy Market Size by Application
7.3.1 Europe Inflammatory Bowel Disease Therapy Market Size by Application (2016-2021)
7.3.2 Europe Inflammatory Bowel Disease Therapy Market Size by Application (2022-2027)
7.3.3 Europe Inflammatory Bowel Disease Therapy Market Size by Application (2016-2027)
7.4 Europe Inflammatory Bowel Disease Therapy Market Size by Country
7.4.1 Europe Inflammatory Bowel Disease Therapy Market Size by Country (2016-2021)
7.4.2 Europe Inflammatory Bowel Disease Therapy Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Inflammatory Bowel Disease Therapy Market Size (2016-2027)
8.2 Asia-Pacific Inflammatory Bowel Disease Therapy Market Size by Type
8.2.1 Asia-Pacific Inflammatory Bowel Disease Therapy Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Inflammatory Bowel Disease Therapy Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Inflammatory Bowel Disease Therapy Market Size by Type (2016-2027)
8.3 Asia-Pacific Inflammatory Bowel Disease Therapy Market Size by Application
8.3.1 Asia-Pacific Inflammatory Bowel Disease Therapy Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Inflammatory Bowel Disease Therapy Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Inflammatory Bowel Disease Therapy Market Size by Application (2016-2027)
8.4 Asia-Pacific Inflammatory Bowel Disease Therapy Market Size by Region
8.4.1 Asia-Pacific Inflammatory Bowel Disease Therapy Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Inflammatory Bowel Disease Therapy Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Inflammatory Bowel Disease Therapy Market Size (2016-2027)
9.2 Latin America Inflammatory Bowel Disease Therapy Market Size by Type
9.2.1 Latin America Inflammatory Bowel Disease Therapy Market Size by Type (2016-2021)
9.2.2 Latin America Inflammatory Bowel Disease Therapy Market Size by Type (2022-2027)
9.2.3 Latin America Inflammatory Bowel Disease Therapy Market Size by Type (2016-2027)
9.3 Latin America Inflammatory Bowel Disease Therapy Market Size by Application
9.3.1 Latin America Inflammatory Bowel Disease Therapy Market Size by Application (2016-2021)
9.3.2 Latin America Inflammatory Bowel Disease Therapy Market Size by Application (2022-2027)
9.3.3 Latin America Inflammatory Bowel Disease Therapy Market Size by Application (2016-2027)
9.4 Latin America Inflammatory Bowel Disease Therapy Market Size by Country
9.4.1 Latin America Inflammatory Bowel Disease Therapy Market Size by Country (2016-2021)
9.4.2 Latin America Inflammatory Bowel Disease Therapy Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Inflammatory Bowel Disease Therapy Market Size (2016-2027)
10.2 Middle East & Africa Inflammatory Bowel Disease Therapy Market Size by Type
10.2.1 Middle East & Africa Inflammatory Bowel Disease Therapy Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Inflammatory Bowel Disease Therapy Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Inflammatory Bowel Disease Therapy Market Size by Type (2016-2027)
10.3 Middle East & Africa Inflammatory Bowel Disease Therapy Market Size by Application
10.3.1 Middle East & Africa Inflammatory Bowel Disease Therapy Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Inflammatory Bowel Disease Therapy Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Inflammatory Bowel Disease Therapy Market Size by Application (2016-2027)
10.4 Middle East & Africa Inflammatory Bowel Disease Therapy Market Size by Country
10.4.1 Middle East & Africa Inflammatory Bowel Disease Therapy Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Inflammatory Bowel Disease Therapy Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Johnson & Johnson
11.1.1 Johnson & Johnson Company Details
11.1.2 Johnson & Johnson Business Overview
11.1.3 Johnson & Johnson Inflammatory Bowel Disease Therapy Introduction
11.1.4 Johnson & Johnson Revenue in Inflammatory Bowel Disease Therapy Business (2016-2021)
11.1.5 Johnson & Johnson Recent Development
11.2 AbbVie
11.2.1 AbbVie Company Details
11.2.2 AbbVie Business Overview
11.2.3 AbbVie Inflammatory Bowel Disease Therapy Introduction
11.2.4 AbbVie Revenue in Inflammatory Bowel Disease Therapy Business (2016-2021)
11.2.5 AbbVie Recent Development
11.3 Takeda Pharmaceutical Company
11.3.1 Takeda Pharmaceutical Company Company Details
11.3.2 Takeda Pharmaceutical Company Business Overview
11.3.3 Takeda Pharmaceutical Company Inflammatory Bowel Disease Therapy Introduction
11.3.4 Takeda Pharmaceutical Company Revenue in Inflammatory Bowel Disease Therapy Business (2016-2021)
11.3.5 Takeda Pharmaceutical Company Recent Development
11.4 Abbott
11.4.1 Abbott Company Details
11.4.2 Abbott Business Overview
11.4.3 Abbott Inflammatory Bowel Disease Therapy Introduction
11.4.4 Abbott Revenue in Inflammatory Bowel Disease Therapy Business (2016-2021)
11.4.5 Abbott Recent Development
11.5 Celgene Corporation
11.5.1 Celgene Corporation Company Details
11.5.2 Celgene Corporation Business Overview
11.5.3 Celgene Corporation Inflammatory Bowel Disease Therapy Introduction
11.5.4 Celgene Corporation Revenue in Inflammatory Bowel Disease Therapy Business (2016-2021)
11.5.5 Celgene Corporation Recent Development
11.6 Innovate Biopharma
11.6.1 Innovate Biopharma Company Details
11.6.2 Innovate Biopharma Business Overview
11.6.3 Innovate Biopharma Inflammatory Bowel Disease Therapy Introduction
11.6.4 Innovate Biopharma Revenue in Inflammatory Bowel Disease Therapy Business (2016-2021)
11.6.5 Innovate Biopharma Recent Development
11.7 Cosmo Pharmaceuticals
11.7.1 Cosmo Pharmaceuticals Company Details
11.7.2 Cosmo Pharmaceuticals Business Overview
11.7.3 Cosmo Pharmaceuticals Inflammatory Bowel Disease Therapy Introduction
11.7.4 Cosmo Pharmaceuticals Revenue in Inflammatory Bowel Disease Therapy Business (2016-2021)
11.7.5 Cosmo Pharmaceuticals Recent Development
11.8 Gilead Sciences
11.8.1 Gilead Sciences Company Details
11.8.2 Gilead Sciences Business Overview
11.8.3 Gilead Sciences Inflammatory Bowel Disease Therapy Introduction
11.8.4 Gilead Sciences Revenue in Inflammatory Bowel Disease Therapy Business (2016-2021)
11.8.5 Gilead Sciences Recent Development
11.9 Pfizer
11.9.1 Pfizer Company Details
11.9.2 Pfizer Business Overview
11.9.3 Pfizer Inflammatory Bowel Disease Therapy Introduction
11.9.4 Pfizer Revenue in Inflammatory Bowel Disease Therapy Business (2016-2021)
11.9.5 Pfizer Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Inflammatory Bowel Disease Therapy Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Ulcerative Colitis
Table 3. Key Players of Crohns Disease
Table 4. Key Players of Others
Table 5. Global Inflammatory Bowel Disease Therapy Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Inflammatory Bowel Disease Therapy Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Inflammatory Bowel Disease Therapy Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Inflammatory Bowel Disease Therapy Market Share by Regions (2016-2021)
Table 9. Global Inflammatory Bowel Disease Therapy Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Inflammatory Bowel Disease Therapy Market Share by Regions (2022-2027)
Table 11. Inflammatory Bowel Disease Therapy Market Trends
Table 12. Inflammatory Bowel Disease Therapy Market Drivers
Table 13. Inflammatory Bowel Disease Therapy Market Challenges
Table 14. Inflammatory Bowel Disease Therapy Market Restraints
Table 15. Global Inflammatory Bowel Disease Therapy Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Inflammatory Bowel Disease Therapy Market Share by Players (2016-2021)
Table 17. Global Top Inflammatory Bowel Disease Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Inflammatory Bowel Disease Therapy as of 2020)
Table 18. Ranking of Global Top Inflammatory Bowel Disease Therapy Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Inflammatory Bowel Disease Therapy Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Inflammatory Bowel Disease Therapy Product Solution and Service
Table 22. Date of Enter into Inflammatory Bowel Disease Therapy Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Inflammatory Bowel Disease Therapy Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Inflammatory Bowel Disease Therapy Revenue Market Share by Type (2016-2021)
Table 26. Global Inflammatory Bowel Disease Therapy Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Inflammatory Bowel Disease Therapy Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Inflammatory Bowel Disease Therapy Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Inflammatory Bowel Disease Therapy Revenue Market Share by Application (2016-2021)
Table 30. Global Inflammatory Bowel Disease Therapy Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Inflammatory Bowel Disease Therapy Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Inflammatory Bowel Disease Therapy Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Inflammatory Bowel Disease Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Inflammatory Bowel Disease Therapy Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Inflammatory Bowel Disease Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Inflammatory Bowel Disease Therapy Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Inflammatory Bowel Disease Therapy Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Inflammatory Bowel Disease Therapy Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Inflammatory Bowel Disease Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Inflammatory Bowel Disease Therapy Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Inflammatory Bowel Disease Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Inflammatory Bowel Disease Therapy Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Inflammatory Bowel Disease Therapy Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Inflammatory Bowel Disease Therapy Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Inflammatory Bowel Disease Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Inflammatory Bowel Disease Therapy Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Inflammatory Bowel Disease Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Inflammatory Bowel Disease Therapy Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Inflammatory Bowel Disease Therapy Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Inflammatory Bowel Disease Therapy Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Inflammatory Bowel Disease Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Inflammatory Bowel Disease Therapy Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Inflammatory Bowel Disease Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Inflammatory Bowel Disease Therapy Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Inflammatory Bowel Disease Therapy Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Inflammatory Bowel Disease Therapy Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Inflammatory Bowel Disease Therapy Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Inflammatory Bowel Disease Therapy Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Inflammatory Bowel Disease Therapy Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Inflammatory Bowel Disease Therapy Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Inflammatory Bowel Disease Therapy Market Size by Country (2022-2027) & (US$ Million)
Table 62. Johnson & Johnson Company Details
Table 63. Johnson & Johnson Business Overview
Table 64. Johnson & Johnson Inflammatory Bowel Disease Therapy Product
Table 65. Johnson & Johnson Revenue in Inflammatory Bowel Disease Therapy Business (2016-2021) & (US$ Million)
Table 66. Johnson & Johnson Recent Development
Table 67. AbbVie Company Details
Table 68. AbbVie Business Overview
Table 69. AbbVie Inflammatory Bowel Disease Therapy Product
Table 70. AbbVie Revenue in Inflammatory Bowel Disease Therapy Business (2016-2021) & (US$ Million)
Table 71. AbbVie Recent Development
Table 72. Takeda Pharmaceutical Company Company Details
Table 73. Takeda Pharmaceutical Company Business Overview
Table 74. Takeda Pharmaceutical Company Inflammatory Bowel Disease Therapy Product
Table 75. Takeda Pharmaceutical Company Revenue in Inflammatory Bowel Disease Therapy Business (2016-2021) & (US$ Million)
Table 76. Takeda Pharmaceutical Company Recent Development
Table 77. Abbott Company Details
Table 78. Abbott Business Overview
Table 79. Abbott Inflammatory Bowel Disease Therapy Product
Table 80. Abbott Revenue in Inflammatory Bowel Disease Therapy Business (2016-2021) & (US$ Million)
Table 81. Abbott Recent Development
Table 82. Celgene Corporation Company Details
Table 83. Celgene Corporation Business Overview
Table 84. Celgene Corporation Inflammatory Bowel Disease Therapy Product
Table 85. Celgene Corporation Revenue in Inflammatory Bowel Disease Therapy Business (2016-2021) & (US$ Million)
Table 86. Celgene Corporation Recent Development
Table 87. Innovate Biopharma Company Details
Table 88. Innovate Biopharma Business Overview
Table 89. Innovate Biopharma Inflammatory Bowel Disease Therapy Product
Table 90. Innovate Biopharma Revenue in Inflammatory Bowel Disease Therapy Business (2016-2021) & (US$ Million)
Table 91. Innovate Biopharma Recent Development
Table 92. Cosmo Pharmaceuticals Company Details
Table 93. Cosmo Pharmaceuticals Business Overview
Table 94. Cosmo Pharmaceuticals Inflammatory Bowel Disease Therapy Product
Table 95. Cosmo Pharmaceuticals Revenue in Inflammatory Bowel Disease Therapy Business (2016-2021) & (US$ Million)
Table 96. Cosmo Pharmaceuticals Recent Development
Table 97. Gilead Sciences Company Details
Table 98. Gilead Sciences Business Overview
Table 99. Gilead Sciences Revenue in Inflammatory Bowel Disease Therapy Business (2016-2021) & (US$ Million)
Table 100. Gilead Sciences Recent Development
Table 101. Pfizer Company Details
Table 102. Pfizer Business Overview
Table 103. Pfizer Inflammatory Bowel Disease Therapy Product
Table 104. Pfizer Revenue in Inflammatory Bowel Disease Therapy Business (2016-2021) & (US$ Million)
Table 105. Pfizer Recent Development
Table 106. Research Programs/Design for This Report
Table 107. Key Data Information from Secondary Sources
Table 108. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Inflammatory Bowel Disease Therapy Market Share by Type: 2020 VS 2027
Figure 2. Ulcerative Colitis Features
Figure 3. Crohns Disease Features
Figure 4. Others Features
Figure 5. Global Inflammatory Bowel Disease Therapy Market Share by Application: 2020 VS 2027
Figure 6. Hospital Case Studies
Figure 7. Medical Research Organization Case Studies
Figure 8. Other Case Studies
Figure 9. Inflammatory Bowel Disease Therapy Report Years Considered
Figure 10. Global Inflammatory Bowel Disease Therapy Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Inflammatory Bowel Disease Therapy Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Inflammatory Bowel Disease Therapy Market Share by Regions: 2020 VS 2027
Figure 13. Global Inflammatory Bowel Disease Therapy Market Share by Regions (2022-2027)
Figure 14. Global Inflammatory Bowel Disease Therapy Market Share by Players in 2020
Figure 15. Global Top Inflammatory Bowel Disease Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Inflammatory Bowel Disease Therapy as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Inflammatory Bowel Disease Therapy Revenue in 2020
Figure 17. Global Inflammatory Bowel Disease Therapy Revenue Market Share by Type (2016-2021)
Figure 18. Global Inflammatory Bowel Disease Therapy Revenue Market Share by Type (2022-2027)
Figure 19. North America Inflammatory Bowel Disease Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Inflammatory Bowel Disease Therapy Market Share by Type (2016-2027)
Figure 21. North America Inflammatory Bowel Disease Therapy Market Share by Application (2016-2027)
Figure 22. North America Inflammatory Bowel Disease Therapy Market Share by Country (2016-2027)
Figure 23. United States Inflammatory Bowel Disease Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Inflammatory Bowel Disease Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Inflammatory Bowel Disease Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Inflammatory Bowel Disease Therapy Market Share by Type (2016-2027)
Figure 27. Europe Inflammatory Bowel Disease Therapy Market Share by Application (2016-2027)
Figure 28. Europe Inflammatory Bowel Disease Therapy Market Share by Country (2016-2027)
Figure 29. Germany Inflammatory Bowel Disease Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Inflammatory Bowel Disease Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Inflammatory Bowel Disease Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Inflammatory Bowel Disease Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Inflammatory Bowel Disease Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Inflammatory Bowel Disease Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Inflammatory Bowel Disease Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Inflammatory Bowel Disease Therapy Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Inflammatory Bowel Disease Therapy Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Inflammatory Bowel Disease Therapy Market Share by Region (2016-2027)
Figure 39. China Inflammatory Bowel Disease Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Inflammatory Bowel Disease Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Inflammatory Bowel Disease Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Inflammatory Bowel Disease Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Inflammatory Bowel Disease Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Inflammatory Bowel Disease Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Inflammatory Bowel Disease Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Inflammatory Bowel Disease Therapy Market Share by Type (2016-2027)
Figure 47. Latin America Inflammatory Bowel Disease Therapy Market Share by Application (2016-2027)
Figure 48. Latin America Inflammatory Bowel Disease Therapy Market Share by Country (2016-2027)
Figure 49. Mexico Inflammatory Bowel Disease Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Inflammatory Bowel Disease Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Inflammatory Bowel Disease Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Inflammatory Bowel Disease Therapy Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Inflammatory Bowel Disease Therapy Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Inflammatory Bowel Disease Therapy Market Share by Country (2016-2027)
Figure 55. Turkey Inflammatory Bowel Disease Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Inflammatory Bowel Disease Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Inflammatory Bowel Disease Therapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Johnson & Johnson Revenue Growth Rate in Inflammatory Bowel Disease Therapy Business (2016-2021)
Figure 59. AbbVie Revenue Growth Rate in Inflammatory Bowel Disease Therapy Business (2016-2021)
Figure 60. Takeda Pharmaceutical Company Revenue Growth Rate in Inflammatory Bowel Disease Therapy Business (2016-2021)
Figure 61. Abbott Revenue Growth Rate in Inflammatory Bowel Disease Therapy Business (2016-2021)
Figure 62. Celgene Corporation Revenue Growth Rate in Inflammatory Bowel Disease Therapy Business (2016-2021)
Figure 63. Innovate Biopharma Revenue Growth Rate in Inflammatory Bowel Disease Therapy Business (2016-2021)
Figure 64. Cosmo Pharmaceuticals Revenue Growth Rate in Inflammatory Bowel Disease Therapy Business (2016-2021)
Figure 65. Gilead Sciences Revenue Growth Rate in Inflammatory Bowel Disease Therapy Business (2016-2021)
Figure 66. Pfizer Revenue Growth Rate in Inflammatory Bowel Disease Therapy Business (2016-2021)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed
炎症性腸疾患療法のグローバル市場：規模・現状・予測2019-2025 Inflammatory bowel disease (IBD) is a chronic inflammatory bowel disease of unknown etiology, mainly including ulcerative colitis (UC) and crohn's disease (CD).The etiology may include environmental, infectious, immune and genetic factors.Because the etiology of inflammatory bowel disease is not cle…- 炎症性腸疾患療法のグローバル市場：規模・現状・予測2019-2025 Inflammatory bowel disease (IBD) is a chronic inflammatory bowel disease of unknown etiology, mainly including ulcerative colitis (UC) and crohn's disease (CD).The etiology may include environmental, infectious, immune and genetic factors.Because the etiology of inflammatory bowel disease is not cle…
- 炎症性腸疾患療法のグローバル市場：規模・現状・予測2019-2025 Inflammatory bowel disease (IBD) is a chronic inflammatory bowel disease of unknown etiology, mainly including ulcerative colitis (UC) and crohn's disease (CD).The etiology may include environmental, infectious, immune and genetic factors.Because the etiology of inflammatory bowel disease is not cle…
- 世界の炎症性腸疾患体外診断市場規模・現状・予測（2021年-2027年） Inflammatory bowel disease is a group of medical conditions that causes chronic inflammation in the digestive tract. The inflammatory bowel disease is an umbrella term which comprises two principal disorders: ulcerative colitis and Crohn’s disease. Ulcerative colitis is a long-term medical indicatio…
- 炎症性腸疾患治療のグローバル市場調査 2019年 The global Inflammatory Bowel Disease Treatment market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Inflammatory Bowel Disease Treatment volume and value at global level, regional level and company leve…